Clinical Trials Directory

Trials / Conditions / Peritoneal Metastases

Peritoneal Metastases

54 registered clinical trials studyying Peritoneal Metastases18 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2)
NCT07411599
M.D. Anderson Cancer CenterPhase 1 / Phase 2
Not Yet RecruitingImpact of an Omega-3 Enriched Oral Nutritional Supplement on Improving Surgical Outcomes in Patients With Peri
NCT07478432
Catholic University of the Sacred HeartN/A
RecruitingA Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal C
NCT07291180
Yale UniversityN/A
RecruitingIntra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
NCT07001592
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Phase 1
RecruitingSystemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for
NCT06519591
Ruijin HospitalPhase 2
Not Yet RecruitingThe Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.
NCT06295094
Odense University HospitalPhase 2
CompletedThe PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilo
NCT06144853
Odense University Hospital
Not Yet RecruitingHIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis
NCT06213519
Sichuan UniversityPhase 2
UnknownDevelopment and Validation of a PSN-AI Prediction Model
NCT06231524
Sixth Affiliated Hospital, Sun Yat-sen University
UnknownRole of PET/CT in Peritoneal Deposits Assessment
NCT06137417
Aya Khaled Mahmoud
WithdrawnIntraperitoneal LSTA1 in CRS-HIPEC
NCT06216561
University of California, San DiegoPhase 1
Not Yet RecruitingNeoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer
NCT05318794
Imperial College LondonPhase 2
RecruitingA Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict
NCT06903325
Fudan University
RecruitingThe Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies
NCT06367270
The University of Hong KongPhase 2
RecruitingOn-treatment Biomarkers in Metastatic Colorectal Cancer for Life
NCT05755672
Region Skane
UnknownSintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Adva
NCT06046963
Zhejiang Cancer HospitalPhase 2
UnknownHyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial
NCT05755685
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2
RecruitingPrediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
NCT05722275
Chinese Academy of Sciences
Not Yet RecruitingHIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
NCT05300945
Zhixin CaoPhase 2 / Phase 3
UnknownIntraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab
NCT06003998
Catharina Ziekenhuis EindhovenPhase 2
TerminatedNear-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma
NCT05687617
Laval UniversityPhase 2
RecruitingIntraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointesti
NCT05277766
University Hospital, GhentPhase 1
TerminatedA Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Tr
NCT05581719
Enlivex Therapeutics RDO Ltd.Phase 1 / Phase 2
Active Not RecruitingDiagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms
NCT05623787
Laval UniversityN/A
TerminatedPhase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aer
NCT05431907
Enlivex Therapeutics RDO Ltd.Phase 1 / Phase 2
UnknownPreoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
NCT05353582
Sun Yat-sen UniversityPhase 2
CompletedConcomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of
NCT05379790
Erasmus Medical CenterPhase 1
CompletedDiagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcino
NCT05340569
Laval UniversityN/A
Not Yet RecruitingHIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction
NCT05095467
Xuefei.WangPhase 2
UnknownNormothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-O
NCT05056389
Oslo University HospitalPhase 1
UnknownIntraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis
NCT04943653
Seoul St. Mary's HospitalPhase 1 / Phase 2
UnknownEfficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric
NCT05204173
Ruijin HospitalPhase 2
RecruitingPIPAC for Peritoneal Metastases
NCT04956068
National Cancer Centre, SingaporePhase 1
RecruitingEfficacy of Hyperthermic Intraperitoneal Chemotherapy
NCT04861558
Uppsala UniversityPhase 3
UnknownPressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peri
NCT04913662
Seoul National University Bundang HospitalPhase 1
CompletedChanges in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment
NCT04744688
University of Aarhus
UnknownctDNA as a Assisted Diagnosis, Early Intervention and Prognostic Marker for Peritoneal Metastases From Colorec
NCT04752930
Sixth Affiliated Hospital, Sun Yat-sen UniversityN/A
UnknownSingle-Cell Transcriptomics of the Peritoneal Microenvironment of Colorectal PC
NCT05676372
University Hospital, Ghent
CompletedThe Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric Cancer
NCT05130710
Tehran University of Medical Sciences
CompletedFeasibility of the LUM Imaging System for Peritoneal Surface Malignancies
NCT03834272
Lumicell, Inc.Phase 1 / Phase 2
UnknownPIPAC for the Treatment of Colorectal Peritoneal Metastases
NCT03868228
Imperial College LondonPhase 1 / Phase 2
WithdrawnCAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (
NCT03682744
Sorrento Therapeutics, Inc.Phase 1
Active Not RecruitingSecond and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal Metastases
NCT03413254
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 3
CompletedHyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
NCT03757858
Capital Medical UniversityPhase 1 / Phase 2
RecruitingAdjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
NCT03280511
Michael Bau MortensenPhase 2
CompletedCirculating Tumour Cells in Patients With Peritoneal Metastases
NCT04083547
Uppsala University
CompletedProphylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT03422432
National Cancer Centre, SingaporeN/A
Active Not RecruitingPerioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
NCT02758951
Koen RoversPhase 2 / Phase 3
CompletedPerioperative Immunonutrition for Patients Undergoing CRS and HIPEC
NCT03430128
National Cancer Centre, SingaporeN/A
CompletedTreatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -
NCT03287375
Michael Bau MortensenPhase 2
CompletedFeasibility of Preoperative Inspiratory Muscle Training for Patients With Peritoneal Metastases
NCT05665257
Uppsala UniversityN/A
CompletedDevelopment of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases
NCT03733184
University of Manchester
CompletedLaparoscopic Staging for Locally Advanced Gastric Cancer in Chinese Patients
NCT02172690
Peking UniversityN/A
CompletedDiffusion-weighted Imaging Study in Cancer of the Ovary
NCT01505829
Institute of Cancer Research, United Kingdom